NanoVibronix Inc.

NanoVibronix Inc.
Stock Exchange OTCBB
EPS
$0.93
Market Cap
$21.42 M
Shares Outstanding
4.12 M
Public Float
2.76 M

Profile

Address
525 Executive Boulevard
New york New York 10523
United States
Employees -
Website http://www.nanovibronix.com
Updated 07/08/2019
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices that target wound healing, and pain therapy and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other.

Financials

View All

Brian M. Murphy
Chief Executive Officer & Director
Harold Jacob
Chief Medical Officer & Director